Supply Chain

Pharmaceutical product distributor continues goal of delivering safe and affordable medication to patients.

How recent advancements in practice and technology have ushered in a new era of pharmaceutical logistics.

Cold chain packaging and logistics provider expands GDP-compliant bonded warehousing services.

How they embrace collaboration will be key to the battle against RSV.

Collaboration aims to expedite the transportation of cancer detection radiopharmaceuticals throughout Chile.

IATA statistics suggest improvement over recent months.

Pharma Commerce provides a synopsis of the presentation.

Stakeholders uncover the obstacles surrounding the industry onboarding process.

Attendees meet to discuss operational issues related to traceability implementation.

Session offers information on industry readiness, plus an overview of a phase implementation recommendation.

In this breakout session, industry leaders discuss understanding and overcoming errors brought on by data challenges.

Pharma Commerce provides a summary of conference breakout session.

Event’s first session aims to analyze the legislation’s implementation, as FDA enforcement is delayed until November 2024.

After concerns raised by multiple supply chain participants over readiness, the agency steps back.

The deal helps the logistics provider—who operates in the healthcare space—continue to grow its services.

Acquisition expands 3PL’s presence in India, adds 7.7 million square feet of facility space.

Guidelines expected to assist companies with EPCIS-based sTI/TS data exchange as they prepare to meet November DSCSA deadlines.

The act is currently set to go into effect in just over three months.

In the midst of providing DSCSA support, the SaaS provider is awarded for being a fast-growing, private US company.

Max Sauberschwarz will become the Group's newest EVP this October.

The finished product, company says, can assist with the medical supply chain’s vaccine distribution process.

Latest IATA stats for the month show that it was only 2.4% below pre-pandemic levels.

Creating a user-centric approach that harnesses both digital tools and behavioral science is key to getting—and maintaining—patients on therapy, and improving clinical, financial, and, ultimately, brand-success outcomes for pharma manufacturers.

Companies' emphasis on delivering pharmaceuticals is evolving into a collaboration focused on healthcare outcomes.

The key questions and considerations for drug manufacturers pursuing an effective alternative distribution model.